EE05530B1 - Solid compositions comprising gamma-amino acid derivatives and a process for their preparation - Google Patents
Solid compositions comprising gamma-amino acid derivatives and a process for their preparationInfo
- Publication number
- EE05530B1 EE05530B1 EEP200000671A EEP200000671A EE05530B1 EE 05530 B1 EE05530 B1 EE 05530B1 EE P200000671 A EEP200000671 A EE P200000671A EE P200000671 A EEP200000671 A EE P200000671A EE 05530 B1 EE05530 B1 EE 05530B1
- Authority
- EE
- Estonia
- Prior art keywords
- gamma
- preparation
- amino acid
- acid derivatives
- solid compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
Abstract
1. Technical Result Increase in efficiency of neuropathologic diseases treatment. 2. Essence A pharmaceutical composition containing as an active compound 4-amino-3-substituted-butanoic acid derivative of the general formula NH2 CH2 - C - CH2 COOH R1 R2 wherein the values R1 and R2, have the values indicated in the description, humectants in pharmaceutically effective amount and pharmaceutically acceptable auxiliaries. The composition is obtained by mixing the mentioned compound, humectant and pharmaceutically acceptable auxiliaries. 3. Field of Application Medicine. Tables: 10
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13312298A JP3761324B2 (en) | 1998-05-15 | 1998-05-15 | Passenger rice transplanter |
PCT/US1999/010186 WO1999059572A1 (en) | 1998-05-15 | 1999-05-10 | Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200000671A EE200000671A (en) | 2002-04-15 |
EE05530B1 true EE05530B1 (en) | 2012-04-16 |
Family
ID=15097314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200000671A EE05530B1 (en) | 1998-05-15 | 1999-05-10 | Solid compositions comprising gamma-amino acid derivatives and a process for their preparation |
Country Status (16)
Country | Link |
---|---|
JP (1) | JP3761324B2 (en) |
CN (1) | CN1171587C (en) |
AT (1) | ATE407668T1 (en) |
CA (1) | CA2325045C (en) |
CY (1) | CY1108488T1 (en) |
DE (1) | DE69939532D1 (en) |
DK (1) | DK1077691T3 (en) |
EA (1) | EA006553B1 (en) |
EE (1) | EE05530B1 (en) |
EG (1) | EG26287A (en) |
ES (1) | ES2312208T3 (en) |
GE (1) | GEP20032987B (en) |
IL (2) | IL139202A0 (en) |
NZ (1) | NZ507162A (en) |
PT (1) | PT1077691E (en) |
UA (1) | UA76398C2 (en) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4904636B2 (en) * | 2001-05-29 | 2012-03-28 | 井関農機株式会社 | Tractor frame |
JP5047022B2 (en) * | 2008-03-24 | 2012-10-10 | ヤンマー株式会社 | Upper and lower split engine storage package connection structure |
WO2013008182A1 (en) * | 2011-07-10 | 2013-01-17 | Mahesh Kandula | Prodrugs of gaba analogs |
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
JP2015519333A (en) | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | Compositions and methods for the treatment of neurological disorders |
WO2013168019A1 (en) * | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neuropathic pain |
WO2013168021A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
WO2013167991A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
WO2013168004A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of fibromyalgia pain |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
WO2013167999A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of neurologic diseases |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9499526B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013168016A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
WO2013167997A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
US20150087674A1 (en) * | 2012-05-10 | 2015-03-26 | Mahesh Kandula | Compositions and methods for the treatment of severe pain |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
CN104583182A (en) | 2012-05-23 | 2015-04-29 | 塞利克斯比奥私人有限公司 | Compositions and methods for treatment of mucositis |
US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
WO2013175347A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
CN104603097A (en) | 2012-05-23 | 2015-05-06 | 塞利克斯比奥私人有限公司 | Compositions and methods for the treatment of multiple sclerosis |
CA2873096A1 (en) | 2012-05-23 | 2013-11-28 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
WO2014037834A2 (en) | 2012-09-08 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of inflammation and lipid disorders |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
WO2014195961A1 (en) | 2013-06-04 | 2014-12-11 | Mahesh Kandula | Compositions and methods for the treatment of diabetes and pre-diabetes |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
CA2976314C (en) | 2014-09-26 | 2021-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
ES2799309T3 (en) | 2014-09-29 | 2020-12-16 | Cellix Bio Private Ltd | Compounds and compositions for the treatment of multiple sclerosis |
CN104352476A (en) * | 2014-10-21 | 2015-02-18 | 齐宏 | Gabapentin capsule and preparation method thereof |
CA2965449C (en) | 2014-10-27 | 2020-11-10 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
CN107428697A (en) | 2015-01-06 | 2017-12-01 | 塞尔利克斯生物私人有限公司 | For treating the composition and method of inflammation and pain |
-
1998
- 1998-05-15 JP JP13312298A patent/JP3761324B2/en not_active Expired - Fee Related
-
1999
- 1999-05-10 ES ES99924164T patent/ES2312208T3/en not_active Expired - Lifetime
- 1999-05-10 DE DE69939532T patent/DE69939532D1/en not_active Expired - Lifetime
- 1999-05-10 AT AT99924164T patent/ATE407668T1/en active
- 1999-05-10 DK DK99924164T patent/DK1077691T3/en active
- 1999-05-10 PT PT99924164T patent/PT1077691E/en unknown
- 1999-05-10 EE EEP200000671A patent/EE05530B1/en unknown
- 1999-05-10 IL IL13920299A patent/IL139202A0/en unknown
- 1999-05-10 EA EA200001154A patent/EA006553B1/en not_active IP Right Cessation
- 1999-05-10 GE GEAP19995678A patent/GEP20032987B/en unknown
- 1999-05-10 CA CA002325045A patent/CA2325045C/en not_active Expired - Lifetime
- 1999-05-10 CN CNB998059781A patent/CN1171587C/en not_active Expired - Fee Related
- 1999-05-10 NZ NZ507162A patent/NZ507162A/en not_active IP Right Cessation
- 1999-05-13 EG EG1999050553A patent/EG26287A/en active
- 1999-10-05 UA UA2000127205A patent/UA76398C2/en unknown
-
2000
- 2000-10-23 IL IL139202A patent/IL139202A/en not_active IP Right Cessation
-
2008
- 2008-11-06 CY CY20081101268T patent/CY1108488T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT1077691E (en) | 2008-11-04 |
JPH11318133A (en) | 1999-11-24 |
DK1077691T3 (en) | 2008-10-27 |
CN1171587C (en) | 2004-10-20 |
IL139202A (en) | 2014-12-31 |
EA200001154A1 (en) | 2001-06-25 |
UA76398C2 (en) | 2006-08-15 |
IL139202A0 (en) | 2001-11-25 |
CA2325045A1 (en) | 1999-11-25 |
NZ507162A (en) | 2003-11-28 |
CY1108488T1 (en) | 2014-04-09 |
JP3761324B2 (en) | 2006-03-29 |
CN1300213A (en) | 2001-06-20 |
ATE407668T1 (en) | 2008-09-15 |
GEP20032987B (en) | 2003-06-25 |
ES2312208T3 (en) | 2009-02-16 |
EE200000671A (en) | 2002-04-15 |
EA006553B1 (en) | 2006-02-24 |
EG26287A (en) | 2013-06-12 |
CA2325045C (en) | 2005-05-03 |
DE69939532D1 (en) | 2008-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE05530B1 (en) | Solid compositions comprising gamma-amino acid derivatives and a process for their preparation | |
GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
GEP20043237B (en) | Pyrazoline Derivatives, Method for Their Preparation and Compositions Containing Them for Treatment of Diseases Mediated by Cyclooxygenase-2 | |
BR9510168A (en) | Polyamino acid compound composition unit dosage form and method for preparing a composition | |
UA44254C2 (en) | DERIVATIVES OF 4- (SUBSTITUTED PHENYLAMINO) QINAZOLINE, METHOD OF THEIR PREPARATION, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION | |
ES2295609T3 (en) | TIADIAZOLILPIPERAZINA DERIVATIVES USEFUL TO TREAT OR PREVENT A PAIN. | |
GEP20043161B (en) | Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators | |
EE200100558A (en) | A triaryl acid derivative, a pharmaceutical composition comprising it, and a compound for therapeutic use | |
MY129473A (en) | 3,3-diarylpropylamines, their use and preparation | |
CA2209167A1 (en) | Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof | |
GEP20033079B (en) | Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency | |
GEP20022654B (en) | Indazole Amide Compounds As Serotoninergic Agents | |
MY128014A (en) | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors | |
FI940696A (en) | New pyrazine derivatives, their preparation and use | |
ATE84045T1 (en) | INHIBITING SUBSTANCES ENKEPHALINASE-B THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS. | |
RU94038256A (en) | Derivatives of pyrazolopyrimidine, method of their synthesis, pharmaceutical compositions based on thereof | |
TR199801229T2 (en) | "Thiol derivatives with metalopeptidase inhibition activity" | |
DE60019086D1 (en) | COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES | |
UA42733C2 (en) | Bis-naphthalimide derivatives and pharmaceutically acceptable acid addition salts thereof, pharmaceutical composition containing them showing cytotoxic activity | |
GEP19991872B (en) | Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same | |
CA2202904A1 (en) | Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases | |
RU94031479A (en) | New application of amino acid derivatives, treatment method, pharmaceutical composition | |
HU903092D0 (en) | Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds | |
SK284317B6 (en) | Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC1A | Change of owner name |